Citations (55)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Xianzhu Ke, Wen Lin, Xiaokang Li, Hailiang Wang, Xin Xiao & Zheng Guo. (2017) Synergistic dual-modified liposome improves targeting and therapeutic efficacy of bone metastasis from breast cancer. Drug Delivery 24:1, pages 1680-1689.
Read now
Read now
Haibin Wu, Meng Wang, Bo Dai, Yanmin Zhang, Ying Yang, Qiao Li, Mingyue Duan, Xi Zhang, Xiaomei Wang, Anmao Li & Liyu Zhang. (2017) Novel CD123-aptamer-originated targeted drug trains for selectively delivering cytotoxic agent to tumor cells in acute myeloid leukemia theranostics. Drug Delivery 24:1, pages 1216-1229.
Read now
Read now
Articles from other publishers (53)
Zahra Abpeikar, Ali Akbar Alizadeh, Leila Rezakhani, Vahid Ramezani, Arash Goodarzi & Mohsen Safaei. (2023) Advantages of Material Biofunctionalization Using Nucleic Acid Aptamers in Tissue Engineering and Regenerative Medicine. Molecular Biotechnology 65:12, pages 1935-1953.
Crossref
Crossref
Jong Won Lee, Man Kyu Shim, Hyosuk Kim, Hochung Jang, Yuhan Lee & Sun Hwa Kim. (2023) RNAi therapies: Expanding applications for extrahepatic diseases and overcoming delivery challenges. Advanced Drug Delivery Reviews 201, pages 115073.
Crossref
Crossref
Pranav, Partha Laskar, Meena Jaggi, Subhash C. Chauhan & Murali M. Yallapu. (2023) Biomolecule-functionalized nanoformulations for prostate cancer theranostics. Journal of Advanced Research 51, pages 197-217.
Crossref
Crossref
Himali Gujrati, Siyoung Ha & Bi-Dar Wang. (2023) Deregulated microRNAs Involved in Prostate Cancer Aggressiveness and Treatment Resistance Mechanisms. Cancers 15:12, pages 3140.
Crossref
Crossref
Sitao Xie, Weidi Sun, Ting Fu, Xiangsheng Liu, Peng Chen, Liping Qiu, Fengli Qu & Weihong Tan. (2023) Aptamer-Based Targeted Delivery of Functional Nucleic Acids. Journal of the American Chemical Society 145:14, pages 7677-7691.
Crossref
Crossref
Pengzhi Shi, Zhangrong Cheng, Kangcheng Zhao, Yuhang Chen, Anran Zhang, Weikang Gan & Yukun Zhang. (2023) Active targeting schemes for nano-drug delivery systems in osteosarcoma therapeutics. Journal of Nanobiotechnology 21:1.
Crossref
Crossref
Mangala Hegde, Nikunj Naliyadhara, Jyothsna Unnikrishnan, Mohammed S. Alqahtani, Mohamed Abbas, Sosmitha Girisa, Gautam Sethi & Ajaikumar B. Kunnumakkara. (2023) Nanoparticles in the diagnosis and treatment of cancer metastases: Current and future perspectives. Cancer Letters 556, pages 216066.
Crossref
Crossref
Anmol Bhatia, Atul Kumar Upadhyay & Siddharth Sharma. (2022)
miRNAs
are now starring in “
No Time to Die
: Overcoming the chemoresistance in cancer”
. IUBMB Life 75:3, pages 238-256.
Crossref
Crossref
Fatima Ghamlouche, Amani Yehya, Yousef Zeid, Hiam Fakhereddine, Jhonny Fawaz, Yen-Nien Liu, Mohamed Al-Sayegh & Wassim Abou-Kheir. (2023) MicroRNAs as clinical tools for diagnosis, prognosis, and therapy in prostate cancer. Translational Oncology 28, pages 101613.
Crossref
Crossref
Wenbo Yang, Qing Pan, Fuhua Huang, Hongzhi Hu & Zengwu Shao. (2023) Research progress of bone metastases: From disease recognition to clinical practice. Frontiers in Oncology 12.
Crossref
Crossref
Xiangzhong Liu, Jing Hu, Yu Ning, Haijia Xu, Hantao Cai, Aofei Yang, Zhengshuai Shi & Zhanghua Li. (2023) Aptamer Technology and Its Applications in Bone Diseases. Cell Transplantation 32, pages 096368972211449.
Crossref
Crossref
Dada Wen, Huamin Zhang, Yutong Zhou & Jie Wang. (2022) The Molecular Mechanisms and Function of miR-15a/16 Dysregulation in Fibrotic Diseases. International Journal of Molecular Sciences 23:24, pages 16041.
Crossref
Crossref
Olga A. Sukocheva, Junqi Liu, Margarita E. Neganova, Narasimha M. Beeraka, Yulia R. Aleksandrova, Prasath Manogaran, Ekaterina M. Grigorevskikh, Vladimir N. Chubarev & Ruitai Fan. (2022) Perspectives of using microRNA-loaded nanocarriers for epigenetic reprogramming of drug resistant colorectal cancers. Seminars in Cancer Biology 86, pages 358-375.
Crossref
Crossref
Beibei Hu, Yongkang Zhang, Guogang Zhang, Zhongqiu Li, Yongshuai Jing, Jun Yao & Shiguo Sun. (2022) Research progress of bone-targeted drug delivery system on metastatic bone tumors. Journal of Controlled Release 350, pages 377-388.
Crossref
Crossref
Xiaoxiang Ren, Xiao Chen, Zhen Geng & Jiacan Su. (2022) Bone-targeted biomaterials: Strategies and applications. Chemical Engineering Journal 446, pages 137133.
Crossref
Crossref
Hailong Tian, Tingting Zhang, Siyuan Qin, Zhao Huang, Li Zhou, Jiayan Shi, Edouard C. Nice, Na Xie, Canhua Huang & Zhisen Shen. (2022) Enhancing the therapeutic efficacy of nanoparticles for cancer treatment using versatile targeted strategies. Journal of Hematology & Oncology 15:1.
Crossref
Crossref
Goknur Kara, Banu Arun, George A. Calin & Bulent Ozpolat. (2022) miRacle of microRNA-Driven Cancer Nanotherapeutics. Cancers 14:15, pages 3818.
Crossref
Crossref
Yunqi Guo, Zhiqiang Wang, Xiangyang Shi & Mingwu Shen. (2022) Engineered cancer cell membranes: An emerging agent for efficient cancer theranostics. Exploration 2:1.
Crossref
Crossref
Shadab Md, Nabil A. Alhakamy, Shahid Karim, Gamal A Gabr, Mohammad Kashif Iqubal & Samar S. A. Murshid. (2021) Signaling Pathway Inhibitors, miRNA, and Nanocarrier-Based Pharmacotherapeutics for the Treatment of Lung Cancer: A Review. Pharmaceutics 13:12, pages 2120.
Crossref
Crossref
Yanan Li, Cangang Zhang, Guo Li, Guowei Deng, Hui Zhang, Yongbing Sun & Feifei An. (2021) Protease-triggered bioresponsive drug delivery for the targeted theranostics of malignancy. Acta Pharmaceutica Sinica B 11:8, pages 2220-2242.
Crossref
Crossref
Esther Campos-Fernández, Nathalia Oliveira Alqualo, Lorrayne Cristina Moura Garcia, Caroline Coutinho Horácio Alves, Tábatha Danielle Ferreira Arantes Vieira, Danilo Caixeta Moreira & Vivian Alonso-Goulart. (2021) The use of aptamers in prostate cancer: A systematic review of theranostic applications. Clinical Biochemistry 93, pages 9-25.
Crossref
Crossref
Panpan Pan, Qin Yue, Juan Li, Meiqi Gao, Xuanyu Yang, Yuan Ren, Xiaowei Cheng, Penglei Cui & Yonghui Deng. (2021) Smart Cargo Delivery System based on Mesoporous Nanoparticles for Bone Disease Diagnosis and Treatment. Advanced Science 8:12.
Crossref
Crossref
Valentina Doldi, Rihan El Bezawy & Nadia Zaffaroni. (2021) MicroRNAs as Epigenetic Determinants of Treatment Response and Potential Therapeutic Targets in Prostate Cancer. Cancers 13:10, pages 2380.
Crossref
Crossref
Giulia Romano, Mario Acunzo & Patrick Nana-Sinkam. (2021) microRNAs as Novel Therapeutics in Cancer. Cancers 13:7, pages 1526.
Crossref
Crossref
Mirazkar D. Pandareesh, Vivek H. Kameshwar & Kullaiah Byrappa. (2021) Prostate Carcinogenesis: Insights in Relation to Epigenetics and Inflammation. Endocrine, Metabolic & Immune Disorders - Drug Targets 21:2, pages 253-267.
Crossref
Crossref
Chiranjib Chakraborty, Ashish Ranjan Sharma, Garima Sharma & Sang-Soo Lee. (2021) Therapeutic advances of miRNAs: A preclinical and clinical update. Journal of Advanced Research 28, pages 127-138.
Crossref
Crossref
Stanislaw Supplitt, Pawel Karpinski, Maria Sasiadek & Izabela Laczmanska. (2021) Current Achievements and Applications of Transcriptomics in Personalized Cancer Medicine. International Journal of Molecular Sciences 22:3, pages 1422.
Crossref
Crossref
Daniel E. Hagaman, Jossana A. Damasco, Joy Vanessa D. Perez, Raniv D. Rojo & Marites P. Melancon. (2021) Recent Advances in Nanomedicine for the Diagnosis and Treatment of Prostate Cancer Bone Metastasis. Molecules 26:2, pages 384.
Crossref
Crossref
JUNQI GUO, YUN YANG, WEI ZHAO, ZHONGHAI YAN, XIA YANG, YUNFEI YAN, RUIMIN HAO, JINXIA HU & FEI JIAO. (2021) MiR-16-5p plays an inhibitory role in human non-small cell lung cancer through Fermitin family member 2. BIOCELL 45:3, pages 627-638.
Crossref
Crossref
Xin Gao, Lin Li, Xiaopan Cai, Quan Huang, Jianru Xiao & Yiyun Cheng. (2021) Targeting nanoparticles for diagnosis and therapy of bone tumors: Opportunities and challenges. Biomaterials 265, pages 120404.
Crossref
Crossref
Hooman Yari, Hariprasad Gali & Vibhudutta Awasthi. (2020) Nanoparticles for Targeting of Prostate Cancer. Current Pharmaceutical Design 26:42, pages 5393-5413.
Crossref
Crossref
Zhaoying Fu & Jim Xiang. (2020) Aptamer-Functionalized Nanoparticles in Targeted Delivery and Cancer Therapy. International Journal of Molecular Sciences 21:23, pages 9123.
Crossref
Crossref
Alessandra Girotti, Sara Escalera-Anzola, Irene Alonso-Sampedro, Juan González-Valdivieso & Francisco Javier Arias. (2020) Aptamer-Functionalized Natural Protein-Based Polymers as Innovative Biomaterials. Pharmaceutics 12:11, pages 1115.
Crossref
Crossref
Gayathri Ravichandran & Aravind Kumar Rengan. (2020) Aptamer-Mediated Nanotheranostics for Cancer Treatment: A Review. ACS Applied Nano Materials 3:10, pages 9542-9559.
Crossref
Crossref
Alexis Forterre, Hiroaki Komuro, Shakhlo Aminova & Masako Harada. (2020) A Comprehensive Review of Cancer MicroRNA Therapeutic Delivery Strategies. Cancers 12:7, pages 1852.
Crossref
Crossref
Zhaoying Fu & Jim Xiang. (2020) Aptamers, the Nucleic Acid Antibodies, in Cancer Therapy. International Journal of Molecular Sciences 21:8, pages 2793.
Crossref
Crossref
Fadwa Odeh, Hamdi Nsairat, Walhan Alshaer, Mohammad A. Ismail, Ezaldeen Esawi, Baraa Qaqish, Abeer Al Bawab & Said I. Ismail. (2019) Aptamers Chemistry: Chemical Modifications and Conjugation Strategies. Molecules 25:1, pages 3.
Crossref
Crossref
Alex Eli Pottash, Christopher Kuffner, Madeleine Noonan-Shueh & Steven M. Jay. (2019) Protein-based vehicles for biomimetic RNAi delivery. Journal of Biological Engineering 13:1.
Crossref
Crossref
Ovidiu Balacescu, Simona Visan, Oana Baldasici, Loredana Balacescu, Catalin Vlad & Patriciu Achimas-Cadariu. 2019. Antisense Therapy. Antisense Therapy.
Saeid Maghsoudi, Bahareh Taghavi Shahraki, Navid Rabiee, Ronak Afshari, Yousef Fatahi, Rassoul Dinarvand, Sepideh Ahmadi, Mojtaba Bagherzadeh, Mohammad Rabiee, Lobat Tayebi & Mohammadreza Tahriri. (2019) Recent Advancements in aptamer-bioconjugates: Sharpening Stones for breast and prostate cancers targeting. Journal of Drug Delivery Science and Technology 53, pages 101146.
Crossref
Crossref
Wen Fu, Wenhua Zhou, Paul K. Chu & Xue‐Feng Yu. (2019) Inherent Chemotherapeutic Anti‐Cancer Effects of Low‐Dimensional Nanomaterials. Chemistry – A European Journal 25:47, pages 10995-11006.
Crossref
Crossref
Isaac Adjei, Madison Temples, Shannon Brown & Blanka Sharma. (2018) Targeted Nanomedicine to Treat Bone Metastasis. Pharmaceutics 10:4, pages 205.
Crossref
Crossref
Walhan Alshaer, Hervé Hillaireau & Elias Fattal. (2018) Aptamer-guided nanomedicines for anticancer drug delivery. Advanced Drug Delivery Reviews 134, pages 122-137.
Crossref
Crossref
Nayer Hosseinahli, Mahyar Aghapour, Pascal H. G. Duijf & Behzad Baradaran. (2018) Treating cancer with microRNA replacement therapy: A literature review. Journal of Cellular Physiology 233:8, pages 5574-5588.
Crossref
Crossref
Mansi Arora & Deepak KaulMansi Arora & Deepak Kaul. 2018. Cancer RNome: Nature & Evolution. Cancer RNome: Nature & Evolution
243
285
.
Qixin Leng, Martin C. Woodle & A. James Mixson. (2017) Targeted Delivery of siRNA Therapeutics to Malignant Tumors. Journal of Drug Delivery 2017, pages 1-22.
Crossref
Crossref
Simon Baumgart & Bernard Haendler. (2017) Exploiting Epigenetic Alterations in Prostate Cancer. International Journal of Molecular Sciences 18:5, pages 1017.
Crossref
Crossref
Yoshitaka Ishihara, Satoshi Tsuno, Satoshi Kuwamoto, Taro Yamashita, Yusuke Endo, Keigo Miura, Yugo Miura, Takemasa Sato, Junichi Hasegawa & Norimasa Miura. (2016) Tumor-suppressive effects of atelocollagen-conjugated hsa-miR-520d-5p on un-differentiated cancer cells in a mouse xenograft model. BMC Cancer 16:1.
Crossref
Crossref
James C Evans, Meenakshi Malhotra, John F Cryan & Caitriona M O'Driscoll. (2016) The therapeutic and diagnostic potential of the prostate specific membrane antigen/glutamate carboxypeptidase II (PSMA/GCPII) in cancer and neurological disease. British Journal of Pharmacology 173:21, pages 3041-3079.
Crossref
Crossref
James C. Evans, Meenakshi Malhotra, Jianfeng Guo, Joseph P. O'Shea, Karen Hanrahan, Amanda O'Neill, William D. Landry, Brendan T. Griffin, Raphael Darcy, R. William Watson & Caitriona M. O'Driscoll. (2016) Folate-targeted amphiphilic cyclodextrin.siRNA nanoparticles for prostate cancer therapy exhibit PSMA mediated uptake, therapeutic gene silencing in vitro and prolonged circulation in vivo. Nanomedicine: Nanotechnology, Biology and Medicine 12:8, pages 2341-2351.
Crossref
Crossref
Jana Merhautova, Regina Demlova & Ondrej Slaby. (2016) MicroRNA-Based Therapy in Animal Models of Selected Gastrointestinal Cancers. Frontiers in Pharmacology 7.
Crossref
Crossref
Balraj Singh Gill, Jimi Marin Alex, Navgeet & Sanjeev Kumar. (2016) Missing link between microRNA and prostate cancer. Tumor Biology 37:5, pages 5683-5704.
Crossref
Crossref
Barbara Mognetti, Giuseppe La Montagna, Maria Giulia Perrelli, Silvia Marino, Pasquale Pagliaro, Cecilia M. Cracco & Claudia Penna. (2014) Zoledronic Acid and Leuprorelin Acetate, Alone or in Combination, Similarly Reduce Proliferation and Migration of Prostate Cancer Cells In Vitro. International Journal of Medical Biology 1, pages 1-7.
Crossref
Crossref